Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Pi-Cardia logo — Leading the way for leaflet modification

Pi-Cardia

Leading the way for leaflet modification

Founded 2009 Israel Israel 59 employees Debt Financing Total: $58.00M Health Care, Medical Devices

General Information

Company Name Pi-Cardia
Founded Year 2009
Location Israel Israel
Founders / Decision Makers
Team member
Employees 59
Industries Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Pi-Cardia. To contact Pi-Cardia, visit pi-cardia.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pi-Cardia compare?

A PDF of Pi-Cardia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pi-Cardia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pi-Cardia

Pi-Cardia, a **medical device company** based in **Israel**, has positioned itself as a **market leader** in developing a diverse range of leaflet modification solutions for treating heart valves. The company boasts extensive knowledge and expertise in degenerated valves, including calcification patterns, mode of valve failure, and the impact of various leaflet modification methods. Their innovative solution, ShortCut™, has been designed to provide a **safe, simple, and effective** way to split leaflets of pre-existing valves, enabling Transcatheter Aortic Valve Replacement (TAVR) in patients at risk of coronary obstruction while assisting in preserving coronary access. Founded in **2009**, Pi-Cardia recently secured a significant **$21.00M Debt Financing** investment, termed as the "Pi investment," on **01 January 2021**. This investment reflects a strong belief in the company's potential to revolutionize the treatment of heart valve conditions and underscores the confidence in its product portfolio. The company's relentless pursuit of innovation in the **Health Care** sector positions it as an intriguing prospect for investors seeking to support transformative advancements in cardiovascular healthcare.

Business keywords: Medical Device, Aortic Stenosis, Catheter System, Cardiovascular Treatment, Innovative Technology, Valve Calcification, Minimally Invasive Surgery, Medical Innovation, Non-surgical Treatment, Heart Health, Cardiology, Valve Fracture, Soft Tissue Preservation, Medical Start-up

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Pi $21.00M -
01 Jan 2021
Venture Round Pi $27.00M 2
Sofinnova Partners
Sofinnova Partners, Jacques R. Seguin
20 Apr 2020
Series C Pi $10.00M 3
Innogest Capital Clal Biotechnology Industries
Innogest Capital, Clal Biotechnology Industries +1
07 Jan 2016
Series C Pi Undisclosed 1
Atlante Ventures
01 Sep 2015
Series B Pi Undisclosed 1
Accelmed Partners
Accelmed Partners
01 Dec 2011
Seed Round Pi Undisclosed 1
Anges Québec
Anges Québec
01 Jan 2010

Pi-Cardia Alternatives & Competitors

View All Alternatives
Pi-Cardia vs
HighLife
HighLife France

Trans-septal Mitral Valve Replacement

Series C
84 employees
Health Care, Medical Devices
Compare Pi-Cardia vs HighLife
Pi-Cardia vs
JenaValve Technology, Inc.
JenaValve Technology, Inc. United States

Aortic regurgitation is different. So is our valve.

Series C
149 employees
Health Care, Manufacturing
Compare Pi-Cardia vs JenaValve Technology, Inc.
Pi-Cardia vs
Protembis GmbH
Protembis GmbH Germany

Full Cerebral Embolic Protection System to Reduce the Risk of Cerebrovascular Events during TAVR/ TA...

Series B
14 employees
Health Care, Health and Wellness
Also compare with: Pi-Cardia vs Cardiawave Cardiawave Pi-Cardia vs Novostia Novostia View all alternatives

FAQ About Pi-Cardia

Leading the way for leaflet modification
Pi-Cardia was founded in 2009.
Pi-Cardia is headquartered in Israel.
Pi-Cardia operates in Health Care and Medical Devices. Its work centres on Medical Device, Aortic Stenosis, Catheter System and Cardiovascular Treatment.
Pi-Cardia has approximately 59 employees.
Pi-Cardia has completed 6 funding rounds, raising a total of $58.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Pi-Cardia include HighLife, JenaValve Technology, Inc., Protembis GmbH, Puzzle Medical Devices Inc., Cardiawave. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pi-Cardia and HighLife are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pi-Cardia, https://bouncewatch.com/company/pi-cardia, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout